Micronesia, Federated States of vs Panama: Immunization, Hib3
Micronesia, Federated States of
71.0%
in 2024
Panama
72.0%
in 2024
Micronesia, Federated States of rank
162nd
Panama rank
160th
Immunization, Hib3 over time
- Micronesia, Federated States of
- Panama
How they compare
Panama currently reports 72.0% against 71.0% in Micronesia, Federated States of, a difference of 1.0%.
Across all 24 years both countries report, Panama has been ahead every year.
Micronesia, Federated States of ranks 162nd and Panama ranks 160th of 191 countries.
Panama has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Micronesia, Federated States of | Panama | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 70.4% | 91.9% | 21.4% | Panama |
| 2010s | 61.5% | 84.2% | 22.7% | Panama |
| 2020s | 63.2% | 77.2% | 14.0% | Panama |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, Micronesia, Federated States of or Panama?
- Panama, at 72.0% against 71.0% in Micronesia, Federated States of as of 2024.
- What is the difference in immunization, hib3 between Micronesia, Federated States of and Panama?
- 1.0%, with Panama ahead.
- How many years of comparable data are there for Micronesia, Federated States of and Panama?
- 24 years are reported by both, from 2001 to 2024.
- How do Micronesia, Federated States of and Panama rank globally for immunization, hib3?
- Micronesia, Federated States of ranks 162nd and Panama ranks 160th of 191 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.